Actemra (tocilizumab) Drug reaction with eosinophilia and systemic symptoms FDA is evaluating the need for regulatory action. Aliqopa (copanlisib) Cytomegalovirus infection FDA is evaluating the need […]
Metacognitive training (MCT) is effective in reducing positive and negative symptoms of schizophrenia, new research suggests. MCT for psychosis is a brief intervention that “combines psychoeducation, […]
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.